Recent insider trading activity from Silberman David, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Silberman David | Chief Financial Officer | A | Common Stock | 136500 | $0.00 | 366,500.0000 | 40,566,901 | 59.35% | 0.34% |